Cronos (CRON) Retained Earnings (2016 - 2026)
Cronos' (CRON) quarterly Retained Earnings came in at -$33.9 million in Q1 2026, up 48.96% year-on-year from -$22.8 million in Q1 2025, and down 101.39% quarter-over-quarter from -$16.8 million in Q4 2025.
Cronos (CRON) Retained Earnings (2016 - 2026) Analysis & Trends
Cronos' Retained Earnings history runs 11 years deep, the most recent figure standing at -$33.9 million for Q1 2026.
- On a quarterly basis, Retained Earnings rose 48.96% year-over-year to -$33.9 million in Q1 2026; TTM through Mar 2026 was -$33.9 million, a 48.96% increase from a year earlier, with the FY2025 full-year figure at -$16.8 million, up 73.49% from the prior year.
- Retained Earnings eased to -$33.9 million in Q1 2026 per CRON's latest filing, from -$16.8 million in the prior quarter.
- Across five years, Retained Earnings topped out at $490.7 million in Q4 2022 and bottomed at -$66.4 million in Q1 2025.
- The 5-year median for Retained Earnings is $1.5 million (2023), against an average of $75.5 million.
- Across the five-year window, Retained Earnings surged 3026.09% in 2024 and tumbled 9228.25% in 2025, its largest moves.
- Year by year, Retained Earnings stood at $490.7 million in 2022, then dropped by 15.07% to $416.7 million in 2023, then slumped by 115.24% to -$63.5 million in 2024, then soared by 73.49% to -$16.8 million in 2025, then tumbled by 101.39% to -$33.9 million in 2026.
- Per Business Quant, the three latest CRON Retained Earnings figures stand at -$33.9 million (Q1 2026), -$16.8 million (Q4 2025), and -$33.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn | -33.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.92 Mn |
| Dec 31, 2025 | -16.84 Mn |
| Sep 30, 2025 | -33.68 Mn |
| Jun 30, 2025 | -8.40 Mn |
| Mar 31, 2025 | -66.45 Mn |
| Dec 31, 2024 | -63.53 Mn |
| Sep 30, 2024 | -361,000.00 |
| Jun 30, 2024 | 405.65 Mn |
| Mar 31, 2024 | 48.05 Mn |
| Dec 31, 2023 | 416.72 Mn |
| Sep 30, 2023 | 47.13 Mn |
| Jun 30, 2023 | 45.32 Mn |
| Mar 31, 2023 | 1.54 Mn |
| Dec 31, 2022 | 490.68 Mn |
| Sep 30, 2022 | -18.98 Mn |
| Jun 30, 2022 | 35.20 Mn |
| Mar 31, 2022 | 35.37 Mn |
| Dec 31, 2021 | 49.87 Mn |
| Sep 30, 2021 | 30.37 Mn |
| Jun 30, 2021 | 32.37 Mn |